Western Financial Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Buy
1,235
+134
+12% +$28.8K 0.09% 106
2026
Q1
$240K Buy
+1,101
New +$244K 0.09% 111
2024
Q1
Sell
-5,915
Closed -$917K 115
2023
Q4
$917K Sell
5,915
-175
-3% -$25.5K 0.61% 30
2023
Q3
$908K Sell
6,090
-611
-9% -$89.7K 0.67% 28
2023
Q2
$903K Buy
6,701
+93
+1% +$13.6K 0.62% 33
2023
Q1
$1.05M Buy
6,608
+199
+3% +$30.4K 0.75% 23
2022
Q4
$1.04M Buy
6,409
+67
+1% +$10.3K 0.67% 26
2022
Q3
$851K Buy
6,342
+388
+7% +$55.7K 0.6% 32
2022
Q2
$912K Buy
+5,954
New +$910K 0.65% 29
2021
Q3
Sell
-1,994
Closed -$225K 89
2021
Q2
$225K Buy
1,994
+35
+2% +$3.94K 0.12% 84
2021
Q1
$212K Hold
1,959
0.13% 79
2020
Q4
$209K Buy
+1,959
New +$188K 0.14% 75

Other funds holding ABBV

Western Financial Corp's ABBV Position: Q2 2026 in Review

Western Financial Corp increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $28.8K and bringing the position to 1,235 shares worth $311K. The position accounts for 0.09% of the portfolio, ranked #106.

Western Financial Corp first reported a position in ABBV in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.05M in Q1 2023. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Western Financial Corp held 1,235 shares of AbbVie worth $311K as of Q2 2026.
  • Western Financial Corp bought 134 AbbVie shares in Q2 2026, an estimated $28.8K.
  • AbbVie made up 0.09% of Western Financial Corp's portfolio in Q2 2026, its #106 holding.
  • Western Financial Corp first reported a position in AbbVie in Q4 2020 and has held it in 12 quarters since.
  • Western Financial Corp's AbbVie position peaked at $1.05M in Q1 2023.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Western Financial Corp's 13F filing for Q2 2026, filed 22 Jul 2026.